BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26472477)

  • 1. Discontinued neuropathic pain therapy between 2009-2015.
    Knezevic NN; Cicmil N; Knezevic I; Candido KD
    Expert Opin Investig Drugs; 2015; 24(12):1631-46. PubMed ID: 26472477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New investigational drugs for the treatment of neuropathic pain.
    Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel sodium channel antagonists in the treatment of neuropathic pain.
    Rivara M; Zuliani V
    Expert Opin Investig Drugs; 2016; 25(2):215-26. PubMed ID: 26576738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging drugs for neuropathic pain.
    Gilron I; Dickenson AH
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):329-41. PubMed ID: 24793304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
    Gentile I; Buonomo AR; Zappulo E; Borgia G
    Expert Opin Investig Drugs; 2015 Feb; 24(2):239-51. PubMed ID: 25384989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinued cardiovascular drugs in 2015.
    Zhao HP; Dai Y; Xiang BR
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1093-101. PubMed ID: 27427204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinued cardiovascular drugs in 2013 and 2014.
    Zhao HP; Xiang BR
    Expert Opin Investig Drugs; 2015; 24(8):1083-92. PubMed ID: 26162717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zucapsaicin for the treatment of neuropathic pain.
    Sałat K; Jakubowska A; Kulig K
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1433-40. PubMed ID: 25171227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends in the management of neuropathic pain.
    McCleane G
    Expert Rev Neurother; 2005 Sep; 5(5):617-23. PubMed ID: 16162085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.
    Noto C; Pappagallo M; Szallasi A
    Curr Opin Investig Drugs; 2009 Jul; 10(7):702-10. PubMed ID: 19579176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinued dermatological drugs in 2014.
    Phuong C; Maibach HI
    Expert Opin Investig Drugs; 2015; 24(11):1483-91. PubMed ID: 26414692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current challenges and future prospects in management of neuropathic pain.
    Jain KK
    Expert Rev Neurother; 2008 Nov; 8(11):1743-56. PubMed ID: 18986244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in neuropathic pain patents.
    Maia RD
    Expert Opin Ther Pat; 2017 May; 27(5):539-546. PubMed ID: 27998196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of anticonvulsants drugs for neuropathic painful conditions.
    Hussain AM; Afshan G
    J Pak Med Assoc; 2008 Dec; 58(12):690-6. PubMed ID: 19157324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.
    Nagoshi N; Fehlings MG
    Expert Opin Investig Drugs; 2015 May; 24(5):645-58. PubMed ID: 25645889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for panic disorder.
    Perna G; Guerriero G; Caldirola D
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):631-45. PubMed ID: 21999303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapy for neuropathic pain.
    Mizoguchi H; Watanabe C; Yonezawa A; Sakurada S
    Int Rev Neurobiol; 2009; 85():249-60. PubMed ID: 19607975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.
    Sawynok J
    Eur J Pain; 2014 Apr; 18(4):465-81. PubMed ID: 24108446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.